These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28030696)

  • 1. Generalizability in Pragmatic Trials.
    Sacristán JA; Dilla T
    JAMA; 2017 Jan; 317(1):87-88. PubMed ID: 28030696
    [No Abstract]   [Full Text] [Related]  

  • 2. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements.
    Nieuwenhuis JB; Irving E; Oude Rengerink K; Lloyd E; Goetz I; Grobbee DE; Stolk P; Groenwold RH; Zuidgeest MG;
    J Clin Epidemiol; 2016 Sep; 77():95-100. PubMed ID: 27164273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalizability in Pragmatic Trials-Reply.
    Sox HC; Lewis RJ
    JAMA; 2017 Jan; 317(1):88. PubMed ID: 28030699
    [No Abstract]   [Full Text] [Related]  

  • 4. Explanatory Versus Pragmatic Trials: An Essential Concept in Study Design and Interpretation.
    Merali Z; Wilson JR
    Clin Spine Surg; 2017 Nov; 30(9):404-406. PubMed ID: 29049130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
    Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
    J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pragmatic clinical trials.
    Macpherson H
    Complement Ther Med; 2004; 12(2-3):136-40. PubMed ID: 15561524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials.
    McMahon AD
    Stat Med; 2002 May; 21(10):1365-76. PubMed ID: 12185890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the confusion and controversies around pragmatic trials: using the Cardiovascular Health Awareness Program (CHAP) trial as an illustrative example.
    Thabane L; Kaczorowski J; Dolovich L; Chambers LW; Mbuagbaw L;
    Trials; 2015 Sep; 16():387. PubMed ID: 26329614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pragmatic trials are important to medical research].
    Bjerre E; Brasso K; Midtgaard J
    Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the design of pragmatic trials: key issues remain.
    Caro JJ; Ishak KJ
    J Comp Eff Res; 2012 Jul; 1(4):319-27. PubMed ID: 24237466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
    Zuidgeest MGP; Goetz I; Groenwold RHH; Irving E; van Thiel GJMW; Grobbee DE;
    J Clin Epidemiol; 2017 Aug; 88():7-13. PubMed ID: 28549929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial quality.
    Moodie EE; Karran JC; Shortreed SM
    Trials; 2016 May; 17(1):242. PubMed ID: 27180047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic design in randomized controlled trials.
    Purgato M; Barbui C; Stroup S; Adams C
    Psychol Med; 2015 Jan; 45(2):225-30. PubMed ID: 25065958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.
    Sonnad SS; Mullins CD; Whicher D; Goldsack JC; Mohr PE; Tunis SR
    Contemp Clin Trials; 2013 Nov; 36(2):356-61. PubMed ID: 23999501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical issues in pragmatic trials of behavioral economic interventions.
    Troxel AB; Asch DA; Volpp KG
    Clin Trials; 2016 Oct; 13(5):478-83. PubMed ID: 27365015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
    van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
    Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study.
    Fransen GA; van Marrewijk CJ; Mujakovic S; Muris JW; Laheij RJ; Numans ME; de Wit NJ; Samsom M; Jansen JB; Knottnerus JA
    BMC Med Res Methodol; 2007 Apr; 7():16. PubMed ID: 17451599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
    Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
    Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.